News

Filter

Current filters:

Licensing

226 to 235 of 97526 results

FDA staffers back approval of Novartis' biosimilar of Amgen's Neupogen

FDA staffers back approval of Novartis' biosimilar of Amgen's Neupogen

06-01-2015

In briefing papers ahead of an advisory committee meeting, agency staff at the US Food and Drug Administration…

AmgenBiosimilarsBiotechnologyImmunologicalsNeupogenNovartisRegulationUSA

Merck and NewLink Ebola vaccine trial to resume after suspension

Merck and NewLink Ebola vaccine trial to resume after suspension

06-01-2015

The Phase I trial of pharma giant Merck & Co’s Ebola vaccine VSV-ZEBOV, developed in conjunction with…

Merck & CoNewLink GeneticsPharmaceuticalResearchSwitzerlandVaccinesVSV-ZEBOV

Leo Pharma files for US approval of first aerosol foam for psoriasis

06-01-2015

Independent Danish dermatology specialist Leo Pharma has submitted a New Drug Application to the US Food…

BetamethasonecalcipotrienecalcipotriolDermatologicalsLEO PharmaPharmaceuticalRegulationUSA

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

06-01-2015

US pharma giant Pfizer has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec,…

Anti-viralsMergers & AcquisitionsPfizerPharmaceuticalRedbiotechRedvaxVaccines

Vectura links with Janssen on asthma/COPD drug development

Vectura links with Janssen on asthma/COPD drug development

06-01-2015

UK inhaled therapies developer Vectura Group has entered into a global development and licence agreement…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingResearchRespiratory and PulmonaryVectura

CytomX expands leadership team with appointment of Michael Kavanaugh as chief scientific officer

CytomX expands leadership team with appointment of Michael Kavanaugh as chief scientific officer

05-01-2015

Oncology biotech company CytomX has appointed Michael Kavanaugh as chief scientific officer and head…

BiotechnologyBoardroomCytomXOncologyUSA

Zynerba Pharmaceuticals appoints Richard Baron as vice president and chief financial officer

Zynerba Pharmaceuticals appoints Richard Baron as vice president and chief financial officer

05-01-2015

Synthetic cannabinoid specialist Zynerba Pharmaceuticals has appointed Richard Baron as vice president…

AnalgesiaBoardroomPharmaceuticalUSAZynerba Pharmaceuticals

Isis Pharma teams up with Janssen on autoimmune disorders in the GI tract

05-01-2015

Isis Pharmaceuticals has entered into a global collaboration with Janssen Biotech, a unit of US health…

BiotechnologyGastro-intestinalsIsis PharmaceuticalsJanssen BiotechJohnson & JohnsonLicensingResearch

226 to 235 of 97526 results

Back to top